OARSI–OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials
Titel:
OARSI–OMERACT initiative: defining thresholds for symptomatic severity and structural changes in disease modifying osteoarthritis drug (DMOAD) clinical trials
Auteur:
Manno, R.L. Bingham III, C.O. Paternotte, S. Gossec, L. Halhol, H. Giacovelli, G. Rovati, L. Mazzuca, S.A. Clegg, D.O. Shi, H. Tajana Messi, E. Lanzarotti, A. Dougados, M.